ABSTRACT Germline genetic testing in the pediatric oncology population remains under‐utilized, despite evidence that 10%–15% of these patients have an underlying genetic cause. Identifying patients with a genetic predisposition can affect diagnosis, treatment, and future surveillance of the patient and family.
Camille Hamilton +14 more
wiley +1 more source
Multimodal chronic pain management in canine osteosarcoma: Palliative strategies.
Sabrina Tsumura +3 more
openalex +1 more source
Statement of Retraction: Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway. [PDF]
europepmc +1 more source
Expression of Concern for PIM3-mediated phosphorylation stabilizes myeloid leukemia factor 2 to promote metastasis in osteosarcoma. [PDF]
Zeng C +15 more
europepmc +1 more source
Salt‐induced nutritional and metabolic shifts in halophytes: implications for food security
Abstract Plant species vary in their response to salinity: some crops show a degree of salt tolerance, while halophytes – whether wild or cultivated – are characterized by a high capacity to thrive under saline conditions. Halophytes are considered a source of valuable secondary metabolites with potential economic value, yet they might also produce ...
Giulia Atzori +9 more
wiley +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
LSM5 is associated with malignant phenotypes in osteosarcoma: an integrative pan-cancer analysis
Hui Deng, Ya-yun Liu, Yuan-xi Leng
openalex +1 more source
Natural Coumarins as ABC Transporters Modulators: A Key Mechanistic Question for Osteosarcoma Chemotherapy. [PDF]
Ren SH.
europepmc +1 more source

